Patent · US Active

Anti-B7-H4 antibodies and immunoconjugates

US12281165B2 · kind B2 · utility

0Cited by

93References

20Claims

0Family size

Assignee

Genentech, Inc. · US

Inventors

Steven Leong · Berkeley, US
Andrew Polson · San Francisco, US
Paul Polakis · Mill Valley, US
Yan Wu · Foster City, US
Wei-Ching Liang · Foster City, US
Ron Firestein · Burlingame, US

Key dates

Filing date	Feb 22, 2022
Grant date	Apr 22, 2025
Priority date	—
Expiry date	Dec 14, 2043

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides anti-B7-H4 antibodies and immunoconjugates and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.